Novel Strategies for Improving Outcomes in Pediatrics with Uncontrolled Moderate-to-Severe Asthma

Target Audience
This activity is designed to meet the educational needs of physicians and other clinicians who work in pediatric pulmonology, allergy, immunology, respiratory, and primary care/internal medicine. This will include (MD/DOs), nurse practitioners (NPs) and physician assistants (PAs) who manage pediatric patients with asthma.

Program Overview
Asthma is one of the most common chronic conditions in the pediatric population, and although existing medications can reduce symptoms, management is still suboptimal. Increased understanding of the pathophysiology of asthma has resulted in novel biologic therapies targeted towards molecules involved in the type 2 inflammatory signaling cascade associated with asthma.

In this roundtable discussion, expert faculty discuss the role of type 2 inflammation in the pathology of asthma, biologic therapies and their role in the treatment of asthma in children and adolescents, and strategies for effective communication with patients and caregivers for optimzing treatment of patients with moderate to severe asthma.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Describe the pathophysiology of type 2 inflammation in asthma
Discuss the role of biologics in the treatment of asthma with type 2 inflammation markers
Formulate treatment plans to manage moderate-to-severe asthma in pediatric patients
Identify strategies for effectively communicating with patients to optimize outcomes in uncontrolled asthma